Recent studies found that dysregulation of SPARC is associated with a variety of obesity-related diseases, including type 2 diabetes and its complications related to obesity, kidney and liver disease, cardiovascular disease, and cancer (23). The gene discussed is SPARC; the disease is liver disorder.